The aim of this survey is to explore the perspective on the use of glucocorticoids (steroids, prednisone) of people with rheumatoid arthritis (RA) around the globe. This survey takes place in addition to and as part of the GLORIA study. GLORIA (The Glucocorticoid Low-dose Outcome in Rheumatoid Arthritis) is an international clinical trial, funded by the European Commission, to investigate the potential benefits and harms of low dose prednisolone (5 mg) in people with Rheumatoid Arthritis (RA). Participation in the clinical trial is not required to complete this survey.
All people with a physician confirmed diagnosis of rheumatoid arthritis of any age above 18 who have personal (past or present) experience with using glucocorticoids are eligible to participate. There are no restrictions to where you live. The study has been approved by the Ethical Review Board of the coordinating GLORIA centre in Portugal.
- Diagnosed by a physician with rheumatoid arthritis (RA)
- Must be at least 18 years old
- Have or are currently taking glucocorticoids (steroids, prednisone)
- 15 minutes
Receive: Help advance understanding of steroid use
This Gig not right for you?
Not to worry! We've got more paid opportunities on the way.
Sign up so you are the first to hear!
(Already have an account - then you're all set!)